|
業務類別
|
Biotechnology |
|
業務概覽
|
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively. |
| 公司地址
| 117 Kendrick Street, Suite 450, Needham, MA, USA, 02494 |
| 電話號碼
| +1 617 916-5445 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.candeltx.com |
| 員工數量
| 42 |
| Ms. Susan Stewart |
Chief Regulatory Officer |
-- |
29/04/2025 |
| Ms. Seshu Tyagarajan, PhD,R.A.C. |
Chief Technical Officer and Chief Development Officer |
美元 401.36K |
29/04/2025 |
| Dr. William Garrett Nichols, M.D.,M.S. |
Chief Medical Officer |
-- |
29/04/2025 |
| Mr. Charles Schoch |
Treasurer, Secretary, Chief Financial Officer and Principal Accounting Officer |
-- |
23/06/2025 |
| Dr. Paul Peter Tak, M.D.,PhD |
President, Chief Executive Officer and Director |
美元 688.94K |
29/04/2025 |
| Dr. Francesca Barone, M.D.,PhD |
Chief Scienctific Officer |
美元 443.30K |
29/04/2025 |
|
|
| Mr. Joseph C. Papa, M.B.A.,R.Ph. |
Independent Director |
29/04/2025 |
| Ms. Mahalakshmi Radhakrishnan, M.D. |
Independent Director |
06/06/2025 |
| Mr. Paul B. Manning |
Chairman of the Board |
29/04/2025 |
| Dr. Edward J. Benz, Jr,M.D. |
Independent Director |
29/04/2025 |
| Ms. Renee M. Gaeta |
Independent Director |
29/04/2025 |
| Dr. Diem Nguyen, M.B.A.,PhD |
Independent Director |
29/04/2025 |
| Dr. Gary J. Nabel, M.D.,PhD |
Independent Director |
29/04/2025 |
| Dr. Paul Peter Tak, M.D.,PhD |
President, Chief Executive Officer and Director |
29/04/2025 |
| Mr. Christopher Martell |
Independent Director |
29/04/2025 |
| Dr. Nicoletta Loggia, PhD,R.Ph. |
Independent Director |
29/04/2025 |
|
|
|
|
